Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Christian O. Henry earned $7.22M in total compensation at Pacific Biosciences of California, including $700.15K salary, $700.15K bonus and $5.81M in stock. Most recently sold 197,814 shares in Sep 2024. Currently holds stock worth $11.83M. 5+ years at the helm of Pacific Biosciences of California.

Compensation History

Annual executive compensation data for Christian O. Henry, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$7.22M

Salary

$700.15K

Bonus

$700.15K

Other

$15.29K

Salary

$700.15K

Board Justification

The compensation philosophy is designed to align executive compensation with company performance, attract and retain key talent, and motivate executives to achieve short-term and long-term corporate objectives.

Bonus

$700.15K

Board Justification

The bonus is based on the achievement of certain pre-established performance criteria, including revenue and cash balance targets, with a payout of 100% of the target bonus opportunity due to meeting these goals in 2023.

Other Compensation

$15.29K

Board Justification

Other compensation includes travel and lodging costs covered by the Company for participation in a sales incentive trip.

Restricted Stock

$5.81M594.69K RSU

Board Justification

The stock awards consist of RSUs that vested in 2023, with the total number of shares vested being 594,687.

Performance Metrics

The performance metrics include revenue targets and cash balance goals, with specific thresholds for bonus payouts.

P

Christian O. Henry

CEO of Pacific Biosciences of California

Education

B.A. in Biochemistry and Cell Biology from the University of California, San Diego; M.B.A. with a concentration in finance from the University of California, Irvine.

Field of Expertise

Business & Management - Business

Sector of Economy

Healthcare

CEO of Pacific Biosciences of California for

5 years 2 months (Sep 2020 - Present)

Previous Experience

Executive Vice President & Chief Commercial Officer of Illumina, Inc.; various senior roles at Affymetrix, Inc., and Nektar Therapeutics.

Holdings

Track Christian O. Henry's stock holdings and portfolio value over time.

Total Stock Sold

$67.96M

ILMN

$59.14M

549,244 ILMN shares

PACB

$8.51M

764,620 PACB shares

DNA

$303.54K

3,674.625 DNA shares

What if they kept their stock?

If Christian O. Henry didn't sell their stock, today they would have:
Extra ILMN549,244 shares worth $70.83M and PACB764,620 shares worth $1.83M and DNA3,674.625 shares worth $33.99K.
This is 6.97% and $4.74M more than what they got when they sold the stock.

Insider Trading

Christian O. Henry's recent stock transactions, purchases, and sales filed with the SEC.

PACB

$345.38K

PACB at $1.75/share

Sep 16, 2024

Sale

WVE

16,115 shares

WVE

Aug 12, 2024

Received

PACB

$69.06K

PACB at $4.87/share

Mar 4, 2024

Sale

PACB

1,605,769 shares

PACB

Feb 22, 2024

Received

PACB

$454.46K

PACB at $5.61/share

Feb 16, 2024

Sale

PACB

$200.00K

PACB at $10.00/share

Dec 14, 2023

Sale

DNA

$6.26K

DNA at $1.39/share

Nov 2, 2023

Sale

DNA

$8.01K

DNA at $1.78/share

Oct 2, 2023

Sale

DNA

$20.24M

DNA at $4.50K/share

Oct 2, 2023

Sale

PACB

$980.25K

PACB at $10.12/share

Sep 18, 2023

Sale

Rivals

Compare Christian O. Henry with competitor CEOs and industry peers.